Collins F M, Carter P B
Infect Immun. 1972 Oct;6(4):451-8. doi: 10.1128/iai.6.4.451-458.1972.
CD-1 mice were vaccinated intragastrically or intramuscularly with one or two doses of 200 mug of heat-killed Salmonella enteritidis 5694. Control mice were vaccinated with sublethal doses of living S. enteritidis Se795. The mice were challenged intragastrically with approximately 10(6)S. enteritidis 5694 SM(R) 7 to 14 days later, and the growth of the challenge population in the liver, spleen, mesenteric lymph nodes, lungs, and intestine was measured quantitatively. Mice receiving two doses of heat-killed vaccine by mouth were able to delay the systemic emergence of a gastrically introduced salmonella infection by 1 to 2 days. The corresponding liver and spleen populations were slightly lower than those seen in the normal controls. On the other hand, mice receiving the living, attenuated vaccine (either intravenously or intragastrically) developed an effective anti-salmonella immunity against subsequent reinfection.
给CD - 1小鼠经胃内或肌肉注射一或两剂200微克热灭活肠炎沙门氏菌5694。对照小鼠接种亚致死剂量的活肠炎沙门氏菌Se795。约7至14天后,给小鼠经胃内接种约10(6)肠炎沙门氏菌5694 SM(R),并定量测定肝脏、脾脏、肠系膜淋巴结、肺和肠道中攻击菌量的增长。经口接受两剂热灭活疫苗的小鼠能够将经胃内引入的沙门氏菌感染的全身出现延迟1至2天。相应的肝脏和脾脏菌量略低于正常对照。另一方面,接受活的减毒疫苗(静脉内或经胃内)的小鼠对随后的再感染产生了有效的抗沙门氏菌免疫力。